JSM 2004 - Toronto

Abstract #301089

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2004 Program page



Activity Number: 438
Type: Contributed
Date/Time: Thursday, August 12, 2004 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #301089
Title: An Application of Repeated Measures Analysis in a Two-period, Longitudinal Cross-over Study
Author(s): Xiaojing Wang*+ and Guanghan F. Liu and Duane Snavely and Al Getson
Companies: Merck & Co., Inc. and Merck & Co., Inc. and Merck & Co., Inc. and Merck & Co., Inc.
Address: 10 Sentry Pkwy., BL3-2, Blue Bell, PA, 19422,
Keywords: crossover study ; longitudinal method ; repeated measures ; analysis of variance
Abstract:

In the early stages of clinical development, cross-over designs are often used to obtain adequate study power with a smaller number of patients. To take full advantage of the crossover design, it requires an assumption of no carry-over effect. Without carry-over effect, the treatment comparison can be made within subject.The study gains more power because within subject variance is usually smaller than between subject variance. When the primary efficacy variable is measured several times within a period, a longitudinal method may be considered for the analysis of the cross-over study data. This method will have some advantage over a conventional statistical analysis method since all observed data can be used in the analysis regardless of whether a patient completes or discontinues prematurely from the study. Statistical tests for sequence and period effects as well as for the treatment comparison of the primary endpoint will be discussed. Simulations will be used to illustrate the method and will be compared with the conventional analysis of variance model.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2004 program

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004